Mark Krystal

8.7k total citations
134 papers, 6.5k citations indexed

About

Mark Krystal is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Mark Krystal has authored 134 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Epidemiology, 59 papers in Infectious Diseases and 51 papers in Virology. Recurrent topics in Mark Krystal's work include HIV/AIDS drug development and treatment (54 papers), HIV Research and Treatment (51 papers) and Influenza Virus Research Studies (45 papers). Mark Krystal is often cited by papers focused on HIV/AIDS drug development and treatment (54 papers), HIV Research and Treatment (51 papers) and Influenza Virus Research Studies (45 papers). Mark Krystal collaborates with scholars based in United States, Germany and United Kingdom. Mark Krystal's co-authors include Peter Palese, Jeffrey D. Parvin, Nicholas A. Meanwell, Christopher Cianci, Masayoshi Enami, Willem Luytjes, Norman Arnheim, Moira Hagen, Susumu Nakada and Laurence Tiley and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark Krystal

132 papers receiving 6.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Krystal United States	45	3.3k	2.7k	1.9k	1.0k	981	134	6.5k
David A. Steinhauer United States	44	4.1k 1.2×	2.7k 1.0×	1.7k 0.9×	1.2k 1.2×	497 0.5×	77	6.9k
Rob W. H. Ruigrok France	52	4.2k 1.3×	4.5k 1.7×	2.1k 1.1×	1.2k 1.2×	936 1.0×	110	8.5k
Michael M. C. Lai United States	65	4.1k 1.3×	3.5k 1.3×	3.8k 2.0×	1.5k 1.4×	679 0.7×	174	12.2k
Sondra Schlesinger United States	49	1.6k 0.5×	3.0k 1.1×	2.5k 1.3×	1.0k 1.0×	547 0.6×	105	7.0k
Brett D. Lindenbach United States	40	4.7k 1.4×	2.7k 1.0×	2.5k 1.3×	1.3k 1.3×	926 0.9×	71	10.5k
Michael M. C. Lai United States	48	2.6k 0.8×	1.9k 0.7×	1.9k 1.0×	1.0k 1.0×	332 0.3×	104	6.5k
Ann D. Kwong United States	37	3.8k 1.2×	1.9k 0.7×	1.9k 1.0×	439 0.4×	396 0.4×	70	6.6k
Henrik Garoff Sweden	54	2.3k 0.7×	3.2k 1.2×	3.7k 1.9×	1.2k 1.2×	1.6k 1.6×	130	9.2k
J K Rose United States	49	2.2k 0.7×	3.0k 1.1×	1.2k 0.6×	1.1k 1.1×	888 0.9×	65	6.5k
Bahige M. Baroudy United States	37	1.1k 0.3×	1.2k 0.4×	1.7k 0.9×	758 0.7×	1.8k 1.9×	65	4.3k

Countries citing papers authored by Mark Krystal

Since Specialization

Citations

This map shows the geographic impact of Mark Krystal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Krystal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Krystal more than expected).

Fields of papers citing papers by Mark Krystal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Krystal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Krystal. The network helps show where Mark Krystal may publish in the future.

Co-authorship network of co-authors of Mark Krystal

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Krystal. A scholar is included among the top collaborators of Mark Krystal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Krystal. Mark Krystal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peese, Kevin M., Samit R. Joshi, Mark Krystal, et al.. (2024). Exploring HIV-1 Maturation: A New Frontier in Antiviral Development. Viruses. 16(9). 1423–1423. 5 indexed citations

McAuliffe, Brian, Jie Chen, Yan Chen, et al.. (2024). Preclinical Profile of the HIV-1 Maturation Inhibitor VH3739937. Viruses. 16(10). 1508–1508.

Subbaiah, Murugaiah A. M., Sarmistha Halder Sinha, Sandhya Mandlekar, et al.. (2022). Improving Drug Delivery While Tailoring Prodrug Activation to Modulate C_max and C_min by Optimization of (Carbonyl)oxyalkyl Linker-Based Prodrugs of Atazanavir. Journal of Medicinal Chemistry. 65(16). 11150–11176. 2 indexed citations

Hartz, Richard A., Li Xu, Sing‐Yuen Sit, et al.. (2022). Synthesis, Structure–Activity Relationships, and In Vivo Evaluation of Novel C-17 Amine Derivatives Based on GSK3640254 as HIV-1 Maturation Inhibitors with Broad Spectrum Activity. Journal of Medicinal Chemistry. 65(23). 15935–15966. 2 indexed citations

Wang, Tao, John F. Kadow, Nicholas A. Meanwell, & Mark Krystal. (2022). The Genesis and Future Prospects of Small Molecule HIV-1 Attachment Inhibitors. Advances in experimental medicine and biology. 1366. 45–64. 2 indexed citations

Subbaiah, Murugaiah A. M., Sarmistha Halder Sinha, Sandhya Mandlekar, et al.. (2020). (Carbonyl)oxyalkyl linker-based amino acid prodrugs of the HIV-1 protease inhibitor atazanavir that enhance oral bioavailability and plasma trough concentration. European Journal of Medicinal Chemistry. 207. 112749–112749. 5 indexed citations

Zhang, Sharon, Neelanjana Ray, Brett R. Beno, et al.. (2019). Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study. PLoS ONE. 14(10). e0224076–e0224076. 14 indexed citations

Subbaiah, Murugaiah A. M., Nicholas A. Meanwell, John F. Kadow, et al.. (2018). Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir. Journal of Medicinal Chemistry. 61(9). 4176–4188. 13 indexed citations

Naidu, B. Narasimhulu, Michael Walker, Margaret E. Sorenson, et al.. (2018). The discovery and preclinical evaluation of BMS-707035, a potent HIV-1 integrase strand transfer inhibitor. Bioorganic & Medicinal Chemistry Letters. 28(12). 2124–2130. 11 indexed citations

10.

Pavía-Ruz, Noris, Xavier Sáez‐Llorens, Torsak Bunupuradah, et al.. (2015). Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age. The Pediatric Infectious Disease Journal. 34(12). 1355–1360. 4 indexed citations

11.

Naidu, B. Narasimhulu, Margaret E. Sorenson, Manoj Patel, et al.. (2014). Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(3). 717–720. 34 indexed citations

12.

Sin, Ny, Brian L. Venables, Keith D. Combrink, et al.. (2009). Respiratory syncytial virus fusion inhibitors. Part 7: Structure–activity relationships associated with a series of isatin oximes that demonstrate antiviral activity in vivo. Bioorganic & Medicinal Chemistry Letters. 19(16). 4857–4862. 36 indexed citations

13.

Dicker, Ira B., Brian Terry, Zeyu Lin, et al.. (2008). Biochemical Analysis of HIV-1 Integrase Variants Resistant to Strand Transfer Inhibitors. Journal of Biological Chemistry. 283(35). 23599–23609. 26 indexed citations

14.

Walker, Michael, Timothy D. Johnson, Jacques Banville, et al.. (2006). Triketoacid inhibitors of HIV-integrase: A new chemotype useful for probing the integrase pharmacophore. Bioorganic & Medicinal Chemistry Letters. 16(11). 2920–2924. 19 indexed citations

15.

Cianci, Christopher, Richard J. Colonno, & Mark Krystal. (1997). Differential effect of modified capped RNA substrates on influenza virus transcription. Virus Research. 50(1). 65–75. 6 indexed citations

16.

Luo, Guangxiang, et al.. (1997). Inhibition of influenza viral polymerases by minimal viral RNA decoys.. Journal of General Virology. 78(9). 2329–2333. 10 indexed citations

17.

Ruan, Li, Peter Palese, & Mark Krystal. (1989). Complementation and analysis of an NP mutant of influenza virus. Virus Research. 12(2). 97–111. 26 indexed citations

18.

Leiter, Josef M.E., Mark Krystal, & Peter Palese. (1989). Expression of antisense RNA fails to inhibit influenza virus replication. Virus Research. 14(2). 141–159. 17 indexed citations

19.

Vlasak, Reinhard, Mark Krystal, Mariana Nacht, & Peter Palese. (1987). The influenza c virus glycoprotein (HE) exhibits receptor-binding (hemagglutinin) and receptor-destroying (esterase) activities. Virology. 160(2). 419–425. 111 indexed citations

20.

Brownell, Elise, Mark Krystal, & Norman Arnheim. (1984). Structure and evolution of human and African ape rDNA pseudogenes.. Molecular Biology and Evolution. 1(1). 29–37. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact